PIK3CA and breast carcinoma: Constitutive activation of the PI3K catalytic domain p110α due to mutations in the PIK3CA gene causes cell migration and metastatic properties in breast cancer cells and is a strong biomarker for the early detection of breast cancer occurrence or recurrence, and is hence used for periodic molecular mammographic screening [99,100].